Browse

Full access

CLO20-038: Data From Electronic Prior Authorization Supports Real-World Evidence Generation: Contemporary Changes in the Treatment of aNSCLC

Full access

CLO20-039: Patient (pt)-Reported Outcomes (PRO) in Patients With HER2-Negative Locally Advanced/Metastatic Breast Cancer (LA/mBC) and a Germline BRCA1/2 Mutation (gBRCA1/2 mut) Receiving Talazoparib vs. Physician’s Choice of Chemotherapy (PCT): A Focus on EMBRACA Racial Subgroups

Full access

CLO20-040: Factors Influencing Survival of Patients Treated for Spinal Metastases at a Regional Cancer Center in Appalachia

Full access

CLO20-041: Prognostic Factors in Major Salivary Gland Tumors Treated with Adjuvant Radiation Therapy

Full access

CLO20-042: The HER2 FISH Ratio is a Predictor of Pathologic Complete Response Among Patients With HER2+ Breast Cancer Receiving Neoadjuvant Anti-HER2 Doublet Therapy Without Chemotherapy

Full access

CLO20-044: Laparoscopic Microwave Ablation for the Treatment of Primary and Metastatic Liver Malignancies

Full access

CLO20-045: Initial Experience of Robotic Assisted Colorectal Surgery in a Community Hospital

Full access

CLO20-046: National Cancer Institute Experience With Generic Anastrozole (Anastrodex, Hikma) in Newly Diagnosed Postmenopausal Female Egyptian Patients With Low Burden Visceral Metastatic Breast Cancer

Full access

CLO20-047: Impact of Treating Physician on Late Treatment Related Morbidity – a Secondary Analysis of a Phase III Randomized Controlled Study in Localized Prostate Cancer

Full access

CLO20-048: Role of TUBB3 Gene Expression in Early and Advanced Breast Cancer Stage Formulation

Filter

You are looking at 91 - 100 of 2,987 items for

CLO20-038: Data From Electronic Prior Authorization Supports Real-World Evidence Generation: Contemporary Changes in the Treatment of aNSCLC

CLO20-039: Patient (pt)-Reported Outcomes (PRO) in Patients With HER2-Negative Locally Advanced/Metastatic Breast Cancer (LA/mBC) and a Germline BRCA1/2 Mutation (gBRCA1/2 mut) Receiving Talazoparib vs. Physician’s Choice of Chemotherapy (PCT): A Focus on EMBRACA Racial Subgroups

CLO20-040: Factors Influencing Survival of Patients Treated for Spinal Metastases at a Regional Cancer Center in Appalachia

CLO20-041: Prognostic Factors in Major Salivary Gland Tumors Treated with Adjuvant Radiation Therapy

CLO20-042: The HER2 FISH Ratio is a Predictor of Pathologic Complete Response Among Patients With HER2+ Breast Cancer Receiving Neoadjuvant Anti-HER2 Doublet Therapy Without Chemotherapy

CLO20-044: Laparoscopic Microwave Ablation for the Treatment of Primary and Metastatic Liver Malignancies

CLO20-045: Initial Experience of Robotic Assisted Colorectal Surgery in a Community Hospital

CLO20-046: National Cancer Institute Experience With Generic Anastrozole (Anastrodex, Hikma) in Newly Diagnosed Postmenopausal Female Egyptian Patients With Low Burden Visceral Metastatic Breast Cancer

CLO20-047: Impact of Treating Physician on Late Treatment Related Morbidity – a Secondary Analysis of a Phase III Randomized Controlled Study in Localized Prostate Cancer

CLO20-048: Role of TUBB3 Gene Expression in Early and Advanced Breast Cancer Stage Formulation

Filter Filter

Browse

You are looking at 91 - 100 of 2,987 items for

Filter